LNTH FY 2014 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

FY 2014 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$302M+6.3% YoY

Gross Profit

$126M41.6% margin

Operating Income

$39M13.1% margin

Net Income

-$4M-1.2% margin

EPS (Diluted)

$-0.20

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

$3M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$250M

Total Liabilities

$489M

Stockholders' Equity

-$239M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$302M	$284M	+6.3%
Gross Profit	$126M	$77M	+62.3%
Operating Income	$39M	-$19M	+308.7%
Net Income	-$4M	-$62M	+94.2%